Published • loading... • Updated
Tumor Splicing Burden Predicts Treatment Response in Kidney Cancer
Among 101 metastatic kidney cancer patients, high splicing burden was tied to better responses to immunotherapy and tyrosine kinase inhibitors, researchers said.
Summary by News Medical
2 Articles
2 Articles
Tumor splicing burden predicts treatment response in kidney cancer
Researchers at City of Hope® and TGen (part of City of Hope) have identified a significant correlation between a tumor's "splicing burden" and its clinical response to treatment for metastatic renal cell carcinoma (mRCC).
·United States
Read Full Article
Study surveys dysfunctional gene splicing in metastatic kidney disease
Researchers at City of Hope and TGen (part of City of Hope) have identified a significant correlation between a tumor's "splicing burden" and its clinical response to treatment for metastatic renal cell carcinoma (mRCC). In a study published in the Journal for ImmunoTherapy of Cancer, researchers demonstrate that patients whose tumor tissue exhibits a high frequency of aberrant gene splicing are more likely to respond to therapy compared to those
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
